Aimmune says peanut allergy drug shows benefit after two years
Aimmune Therapeutics Inc said on Monday 80% of patients being treated with its drug Palforzia were successfully desensitized to peanut proteins after two years of...
S&P 500, Dow extend rally on hopes of swift economic rebound
Wall Street’s major indexes rose on Monday, building on last week’s sharp gains after a surprisingly upbeat jobs report raised bets of a swift recovery...
U.S. authorities seek to question UK’s Prince Andrew over Epstein
The U.S. Department of Justice is seeking to question Britain’s Prince Andrew as part of its investigation into possible co-conspirators of deceased financier and convicted...
Breakingviews TV: High wire
HSBC Chairman Mark Tucker is walking a tightrope in Hong Kong. The $108 bln bank must placate China’s government, which is exerting more control over...
Saudi Arabia considers limiting haj pilgrims amid COVID-19 fears
Saudi Arabia could drastically limit numbers at the annual haj pilgrimage to prevent a further outbreak of coronavirus after cases in the country topped 100,000,...
U.S. authorities seek to question UK’s Prince Andrew over Epstein, source says
The U.S. Department of Justice is seeking to question Britain’s Prince Andrew as part of its investigation into possible co-conspirators of deceased financier and convicted...
China drops Shanghai as a first port of entry for Beijing-bound flights
China on Monday dropped Shanghai as one of the first ports of entry for international flights bound for the capital, Beijing, while four new cities...
The future is orange: Campari tests selling Aperol in China
Campari is testing selling Aperol in China as the Italian spirits group looks to its photogenic orange-flavoured aperitif to revive sales hit by the coronavirus...
EU watchdog assessing Gilead application for COVID-19 treatment
The European health regulator said on Monday it had received an application from U.S. drugmaker Gilead Sciences Inc for approval of its antiviral drug, remdesivir,...
Floyd’s death spurs ‘Gen Z’ activists to set up new D.C. rights group
Jacqueline LaBayne and Kerrigan Williams met for the very first time in person on Wednesday, at a sit-in they organized in front of the U.S....